Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 3
1967 14
1968 14
1969 22
1970 33
1971 27
1972 33
1973 20
1974 31
1975 11
1976 27
1977 21
1978 16
1979 23
1980 23
1981 34
1982 31
1983 30
1984 39
1985 50
1986 41
1987 42
1988 40
1989 68
1990 64
1991 53
1992 44
1993 52
1994 58
1995 59
1996 48
1997 70
1998 48
1999 72
2000 56
2001 52
2002 74
2003 84
2004 74
2005 97
2006 95
2007 99
2008 90
2009 137
2010 146
2011 149
2012 183
2013 197
2014 216
2015 216
2016 214
2017 216
2018 259
2019 100
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3,721 results
Results by year
Filters applied: . Clear all
Page 1
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.
Peng Y, et al. Medicine (Baltimore) 2016 - Review. PMID 26937922 Free PMC article.
Child-Pugh and MELD scores have been widely used for the assessment of prognosis in liver cirrhosis. A systematic review and meta-analysis aimed to compare the discriminative ability of Child-Pugh versus MELD score to assess the prognosis of cirrhotic patients.PubMed and EMBASE databases were searched. ...In patients with acute-on-chronic liver failure, Child-Pugh score had a higher sensitivity and a lower specificity than MELD score. ...
Child-Pugh and MELD scores have been widely used for the assessment of prognosis in liver cirrhosis. A systematic review and m …
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
Hagström H, et al. J Hepatol 2017. PMID 28803953
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is very common in the general population, but identifying patients with increased risk of mortality and liver-specific morbidity remains a challenge. ...Outcomes on mortality and severe liver disease, defined as cirrhosis, liver decompensation/failure or hepatocellular carcinoma, were evaluated using population-based registers. ...
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) is very common in the general population, but identifying patients w …
Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe.
Zatoński WA, et al. Eur Addict Res 2010. PMID 20606444
BACKGROUND AND AIMS: Over the last decades, Europe has experienced dramatic changes in the geographical variation of liver cirrhosis rates. We attempt to provide a comprehensive analysis of patterns and trends in liver cirrhosis mortality in European countries and regions. ...
BACKGROUND AND AIMS: Over the last decades, Europe has experienced dramatic changes in the geographical variation of liver cirrhos
Effects of branched chain amino acid supplementation on patient care outcomes in adults and children with liver cirrhosis: A systematic review.
Ooi PH, et al. Clin Nutr ESPEN 2018. PMID 30390892
BACKGROUND & AIMS: Malnutrition is highly prevalent in chronic liver disease (CLD) due to alterations in nutrient utilization, malabsorption and poor intake. Low serum concentrations of branched chain amino acids (BCAA) in the presence of elevated aromatic acid concentrations is commonly observed in adult and children with liver cirrhosis and is associated with malnutrition and other adverse patient outcomes. ...
BACKGROUND & AIMS: Malnutrition is highly prevalent in chronic liver disease (CLD) due to alterations in nutrient utilization, ma …
The role of birth cohorts in long-term trends in liver cirrhosis mortality across eight European countries.
Trias-Llimós S, et al. Addiction 2017. PMID 27633487
This study estimated the relative contributions of birth cohorts to liver cirrhosis mortality trends and compared sex- and country-specific cohort patterns across eight European countries. ...MEASUREMENTS: We modelled country- and sex-specific liver cirrhosis mortality (from national vital registers) adjusting for age, period and birth cohort. ...
This study estimated the relative contributions of birth cohorts to liver cirrhosis mortality trends and compared sex- and cou …
Declining mortality in critically ill patients with cirrhosis in Australia and New Zealand between 2000 and 2015.
Majumdar A, et al. J Hepatol 2017. PMID 28802877
No difference was seen in the adjusted decline in mortality of patients with cirrhosis when stratified by mechanical ventilation (p=0.92), liver transplant centre status (p=0.27) or presence of sepsis (p=0.09). ...Outcomes are similar between non-liver transplant ICUs and liver transplant centres. LAY SUMMARY: The outcomes of patients with liver cirrhosis admitted to intensive care units (ICUs) have been previously regarded as poor. ...
No difference was seen in the adjusted decline in mortality of patients with cirrhosis when stratified by mechanical ventilation (p=0 …
Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis.
Mindikoglu AL, et al. Transl Res 2018. PMID 29291380 Free PMC article.
Among the 1028 metabolites identified, 34 were significantly increased in subjects with high liver and kidney disease severity compared with those with low liver and kidney disease severity. ...A unique metabolomic signature associated with hepatorenal dysfunction in cirrhosis was identified for further investigations that provide potentially important mechanistic insights into cirrhosis-altered metabolism....
Among the 1028 metabolites identified, 34 were significantly increased in subjects with high liver and kidney disease severity compar …
qSOFA score not predictive of in-hospital mortality in emergency patients with decompensated liver cirrhosis.
Müller M, et al. Med Klin Intensivmed Notfmed 2019 - Clinical Trial. PMID 30132026
METHODS: This observational study included patients admitted with the diagnosis of decompensated liver cirrhosis. All patients with a complete set of vital parameters were included in this study. ...CONCLUSION: qSOFA does not predict in-hospital mortality, ICU admission or length of hospitalisation in patients with decompensated liver cirrhosis. ...
METHODS: This observational study included patients admitted with the diagnosis of decompensated liver cirrhosis. All patients …
3,721 results
Jump to page
Feedback